prednimustine has been researched along with Leukocytopenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dombernowsky, P; Krusenstjerna-Hofstrom, D; Løber, J; Mattsson, W; Mouridsen, HT; Rørth, M | 1 |
| Dombernowsky, P; Kristensen, D; Mouridsen, HT; Nielsen, JH | 1 |
| Dusleag, J; Kasparek, AK; Lechner, P; Pfeiffer, K; Samonigg, H; Schmid, M; Smola, M; Steindorfer, P; Stöger, H | 1 |
1 trial(s) available for prednimustine and Leukocytopenia
| Article | Year |
|---|---|
A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Topics: Adult; Aged; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leukopenia; Middle Aged; Prednimustine; Prednisolone; Random Allocation | 1980 |
2 other study(ies) available for prednimustine and Leukocytopenia
| Article | Year |
|---|---|
Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Chlorambucil; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nausea; Prednimustine; Psychoses, Substance-Induced; Thrombocytopenia; Time Factors; Vomiting | 1980 |
Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chi-Square Distribution; Drug Evaluation; Female; Fluorouracil; Humans; Leukopenia; Middle Aged; Mitoxantrone; Nausea; Prednimustine; Remission Induction; Survival Rate; Thrombocytopenia; Vomiting | 1991 |